Procainamide-induced lupus anticoagulant
| Autor: | Carliner Nh, Heyman Mr, Flores Rh, Edelman Bb |
|---|---|
| Rok vydání: | 1988 |
| Předmět: |
Male
medicine.medical_specialty Procainamide Internal medicine Medicine Humans In patient Prospective cohort study Blood Coagulation Aged Autoantibodies Lupus anticoagulant Systemic lupus erythematosus business.industry Incidence (epidemiology) General Medicine medicine.disease Thrombosis Blood Coagulation Factors Increased risk Lupus Coagulation Inhibitor Prothrombin Time Female Partial Thromboplastin Time business medicine.drug |
| Zdroj: | Southern medical journal. 81(7) |
| ISSN: | 0038-4348 |
| Popis: | The lupus anticoagulant, with or without other symptoms or signs of lupus, has been described in patients taking procainamide. Screening all such patients for the presence of these anticoagulants may be warranted (despite the rarity of episodes of bleeding) in view of the potentially increased risk of thrombotic events in patients who may already be predisposed. A prospective study to determine the incidence of lupus anticoagulant in procainamide-treated patients and the true frequency of thrombosis in these patients would be helpful in determining appropriate management. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|